CARM

0.00020.00%
NM

Natalie McAndrew

Consultant & Principle Accounting Officer

Ms. Natalie McAndrew is Vice President of Finance of Carisma Therapeutics, Inc. She has been Consultant and Principle Accounting Officer of Baudax Bio, Inc. since December 2023 and was its Interim Chief Financial Officer since October 9, 2023 until December 2023. Ms. McAndrew is a Director with Danforth and has been employed with Danforth since August 2021. Prior to Danforth, Ms. McAndrew was the Vice President, Corporate Controller of Tmunity Therapeutics, Inc., a biotechnology company, from January 2021 to July 2021. Ms. McAndrew previously served as Head of Accounting Operations at Spark Therapeutics, Inc., a biotechnology company, from March 2015 until January 2021. Prior to this, Ms. McAndrew served as Corporate Controller in other privately held and public companies at various life cycle stages, managing finance, accounting and other corporate operational functions. Ms. McAndrew is a certified public accountant and holds a B.S. degree in Accounting from King’s College.

Positions